Gautam Wali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gautam Wali has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Yan Li
Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, USA
7 shared publicationsCarolyn M. Sue
Neuroscience Research Australia (NeuRA), Sydney, Australia
6 shared publicationsMelanie Zhong
The University of Sydney, Brain and Mind Centre & Faculty of Medicine and Health School of Medical Sciences, Sydney, Australia
4 shared publications- Nicolas Dzamko
Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, Australia
4 shared publications Adahir Labrador-Garrido
Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, USA
3 shared publicationsDad Abu-Bonsrah
Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, USA
3 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Springer Nature in Molecular Neurodegeneration Advances
- Vol. 2 (1) , 48
Quantitative cellular morphology in neurodegenerative and neuropsychiatric diseases: insights into disease mechanisms and therapeutic discovery
Background: Neurodegenerative and neuropsychiatric diseases are characterised by complex cellular pathology involving coordinated alterations across multiple subcellular components. Advances in high-content imaging, multiplexed fluorescent labelling, and quantitative image analysis now allow systematic measurement of cellular morphology, closely linked to cellular function, at single-cell resolution in human-derived models. These developments have enabled the emergence of cell morphomics , a quantitative framework that captures changes in cellular and subcellular morphology across disease and drug treatment response contexts. Main body: Here, we systematically review studies published over the past five years applying high-content imaging with quantitative morphometric analysis in human cellular models of neurological disease. Searches of PubMed, Embase, and Scopus identified 33 eligible studies spanning Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, hereditary spastic paraplegia, Huntington’s disease, dominant optic atrophy, and neurodevelopmental and neuropsychiatric conditions including, schizophrenia and autism spectrum disorder. Across genetic, sporadic, and environmental contexts, these studies reveal coordinated morphological alterations across multiple subcellular compartments including, mitochondria, lysosomes, nucleus, cytoskeleton, and endoplasmic reticulum, with both disease-specific and partially convergent subcellular phenotypes emerging within and between diseases. Within idiopathic cohorts, morphomic analyses reveal marked intra-group variability in cellular and subcellular morphology, indicating underlying mechanistic heterogeneity. Cellular context further shapes disease-associated morphology, as neuronal and non-neuronal models from the same disease differ in the magnitude and integration of structural alterations. Machine learning approaches integrate high-dimensional morphomic features for patient group classification and prediction, identify the subcellular components driving group differences, and characterise changes following therapeutic perturbation. In multiple studies, these morphological alterations correspond with independent functional measures, supporting quantitative cellular morphology as a biologically relevant intermediate phenotype. Conclusion: Together, these findings position cell morphomics as a scalable and human-relevant intermediate phenotype linking molecular alterations with functional outcome. As patient-derived cellular models increasingly drive translational neuroscience and early-phase drug discovery, quantitative cellular morphology provides an analytical approach for understanding disease mechanisms and evaluating therapeutic response across neurological disorders.
- 9 October 2026
- Published by Springer Nature in Molecular Neurodegeneration Advances
- Vol. 2 (1) , 48
Open AccessQuantitative cellular morphology in neurodegenerative and neuropsychiatric diseases: insights into disease mechanisms and therapeutic discovery
Background: Neurodegenerative and neuropsychiatric diseases are characterised by complex cellular pathology involving coordinated alterations across multiple subcellular components. Advances in high-content imaging, multiplexed fluorescent labelling, and quantitative image analysis now allow systematic measurement of cellular morphology, closely linked to cellular function, at single-cell resolution in human-derived models. These developments have enabled the emergence of cell morphomics , a quantitative framework that captures changes in cellular and subcellular morphology across disease and drug treatment response contexts. Main body: Here, we systematically review studies published over the past five years applying high-content imaging with quantitative morphometric analysis in human cellular models of neurological disease. Searches of PubMed, Embase, and Scopus identified 33 eligible studies spanning Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, hereditary spastic paraplegia, Huntington’s disease, dominant optic atrophy, and neurodevelopmental and neuropsychiatric conditions including, schizophrenia and autism spectrum disorder. Across genetic, sporadic, and environmental contexts, these studies reveal coordinated morphological alterations across multiple subcellular compartments including, mitochondria, lysosomes, nucleus, cytoskeleton, and endoplasmic reticulum, with both disease-specific and partially convergent subcellular phenotypes emerging within and between diseases. Within idiopathic cohorts, morphomic analyses reveal marked intra-group variability in cellular and subcellular morphology, indicating underlying mechanistic heterogeneity. Cellular context further shapes disease-associated morphology, as neuronal and non-neuronal models from the same disease differ in the magnitude and integration of structural alterations. Machine learning approaches integrate high-dimensional morphomic features for patient group classification and prediction, identify the subcellular components driving group differences, and characterise changes following therapeutic perturbation. In multiple studies, these morphological alterations correspond with independent functional measures, supporting quantitative cellular morphology as a biologically relevant intermediate phenotype. Conclusion: Together, these findings position cell morphomics as a scalable and human-relevant intermediate phenotype linking molecular alterations with functional outcome. As patient-derived cellular models increasingly drive translational neuroscience and early-phase drug discovery, quantitative cellular morphology provides an analytical approach for understanding disease mechanisms and evaluating therapeutic response across neurological disorders.
- Open Access
- 1 August 2026
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 12 (1)
Machine learning image analysis predicts Parkinson disease genotype and mitochondrial lysosomal abnormalities in iPS neurons
Mitochondrial and lysosomal dysfunction are central features of Parkinson’s disease (PD) across major genetic forms including PRKN , SNCA , and LRRK2 . We applied cell morphomics , a machine-learning-based framework combining high-content imaging with quantitative feature extraction, to analyse mitochondrial and lysosomal morphology at single-cell resolution in iPS cell-derived cortical neurons from PD patients and healthy controls (13 lines total). Supervised machine-learning models distinguished PD neurons from controls with high accuracy (AUC = 0.87) and reliably separated individual genotypes. Feature importance and attribution analysis revealed genotype-specific organelle biases in the relative contribution of mitochondrial and lysosomal features, with mitochondrial features dominating classification in PRKN neurons, balanced mitochondrial and lysosomal contributions in SNCA neurons, and a greater lysosomal contribution in LRRK2 neurons. Multi-class models retained strong performance, and findings were reproduced across two independent laboratories using different dyes and imaging conditions. These results demonstrate that morphomics provides a robust and scalable framework to quantify genotype-specific organelle abnormalities in PD neurons and supports its application for cellular stratification and biomarker discovery.
- 1 August 2026
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 12 (1)
Open AccessMachine learning image analysis predicts Parkinson disease genotype and mitochondrial lysosomal abnormalities in iPS neurons
Mitochondrial and lysosomal dysfunction are central features of Parkinson’s disease (PD) across major genetic forms including PRKN , SNCA , and LRRK2 . We applied cell morphomics , a machine-learning-based framework combining high-content imaging with quantitative feature extraction, to analyse mitochondrial and lysosomal morphology at single-cell resolution in iPS cell-derived cortical neurons from PD patients and healthy controls (13 lines total). Supervised machine-learning models distinguished PD neurons from controls with high accuracy (AUC = 0.87) and reliably separated individual genotypes. Feature importance and attribution analysis revealed genotype-specific organelle biases in the relative contribution of mitochondrial and lysosomal features, with mitochondrial features dominating classification in PRKN neurons, balanced mitochondrial and lysosomal contributions in SNCA neurons, and a greater lysosomal contribution in LRRK2 neurons. Multi-class models retained strong performance, and findings were reproduced across two independent laboratories using different dyes and imaging conditions. These results demonstrate that morphomics provides a robust and scalable framework to quantify genotype-specific organelle abnormalities in PD neurons and supports its application for cellular stratification and biomarker discovery.
- 14 July 2026
- Published by EMBL-EBI
Machine learning image analysis predicts Parkinson disease genotype and mitochondrial lysosomal abnormalities in iPS neurons
BioStudies – one package for all the data supporting a study
- 14 July 2026
- Published by EMBL-EBI
Machine learning image analysis predicts Parkinson disease genotype and mitochondrial lysosomal abnormalities in iPS neurons
BioStudies – one package for all the data supporting a study
- Open Access
- 10 July 2026
- Published by Springer Nature
Immunocytochemistry for characterisation of human iPSC-derived cortical neurons v1
This protocol describes immunocytochemistry for characterisation of differentiated human iPSC-derived cortical cells. Cells are stained with microtubule-associated protein 2 (MAP2) as a general neuronal marker, COUP-TF-interacting protein 2 (CTIP2) to identify layer V cortical neurons, and T-box brain protein 1 (TBR1) to identify deep-layer V/VI cortical neurons. The protocol uses CytoFix/CytoPerm fixation and permeabilisation, followed by primary antibody incubation, fluorescent secondary antibody incubation, Hoechst nuclear counterstaining, washing, plate sealing and storage at 4 °C in the dark until imaging.
- 10 July 2026
- Published by Springer Nature
Open AccessImmunocytochemistry for characterisation of human iPSC-derived cortical neurons v1
This protocol describes immunocytochemistry for characterisation of differentiated human iPSC-derived cortical cells. Cells are stained with microtubule-associated protein 2 (MAP2) as a general neuronal marker, COUP-TF-interacting protein 2 (CTIP2) to identify layer V cortical neurons, and T-box brain protein 1 (TBR1) to identify deep-layer V/VI cortical neurons. The protocol uses CytoFix/CytoPerm fixation and permeabilisation, followed by primary antibody incubation, fluorescent secondary antibody incubation, Hoechst nuclear counterstaining, washing, plate sealing and storage at 4 °C in the dark until imaging.
- Open Access
- 9 July 2026
- Published by Springer Nature
Live-cell mitochondrial and lysosomal imaging assays in human iPSC-derived cortical neurons v1
This protocol describes live-cell fluorescence imaging assays used to assess mitochondrial and lysosomal phenotypes in human iPSC-derived cortical neurons cultured in 96-well imaging plates. Two assay formats are described: a mitochondrial and lysosomal morphology assay using MitoTracker Deep Red, Lysotracker staining reagent, Cytopainter Green and Hoechst 33342; and a TMRM-mitochondrial assay using Calcein, TMRM and Hoechst 33342. Cells are stained in culture medium, washed, and imaged immediately using an Opera Phenix high-content imaging system.
- 9 July 2026
- Published by Springer Nature
Open AccessLive-cell mitochondrial and lysosomal imaging assays in human iPSC-derived cortical neurons v1
This protocol describes live-cell fluorescence imaging assays used to assess mitochondrial and lysosomal phenotypes in human iPSC-derived cortical neurons cultured in 96-well imaging plates. Two assay formats are described: a mitochondrial and lysosomal morphology assay using MitoTracker Deep Red, Lysotracker staining reagent, Cytopainter Green and Hoechst 33342; and a TMRM-mitochondrial assay using Calcein, TMRM and Hoechst 33342. Cells are stained in culture medium, washed, and imaged immediately using an Opera Phenix high-content imaging system.
- Open Access
- 9 July 2026
- Published by Springer Nature
High-content confocal imaging of human iPSC-derived cortical neurons using the Opera Phenix Plus system v1
This protocol describes high-content confocal image acquisition of human iPSC-derived cortical neurons using the Opera Phenix Plus high-content screening system. Images are acquired using 20× or 40× water-immersion objectives, spinning-disk confocal detection, laser-based illumination and monochrome sCMOS camera detection. Image acquisition is performed using Harmony software v5.2, with images saved in 16-bit TIFF format. The protocol is suitable for live-cell fluorescence imaging assays assessing mitochondrial and lysosomal phenotypes.
- 9 July 2026
- Published by Springer Nature
Open AccessHigh-content confocal imaging of human iPSC-derived cortical neurons using the Opera Phenix Plus system v1
This protocol describes high-content confocal image acquisition of human iPSC-derived cortical neurons using the Opera Phenix Plus high-content screening system. Images are acquired using 20× or 40× water-immersion objectives, spinning-disk confocal detection, laser-based illumination and monochrome sCMOS camera detection. Image acquisition is performed using Harmony software v5.2, with images saved in 16-bit TIFF format. The protocol is suitable for live-cell fluorescence imaging assays assessing mitochondrial and lysosomal phenotypes.
- Open Access
- 17 March 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Slow motion videography in Parkinson’s disease: unraveling masked phenomenology
Slow motion (SM) videography provides a novel approach to documenting and understanding movement disorders by revealing subtle phenomenological features no
- 17 March 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessSlow motion videography in Parkinson’s disease: unraveling masked phenomenology
Slow motion (SM) videography provides a novel approach to documenting and understanding movement disorders by revealing subtle phenomenological features no
- Open Access
Machine learning–based image analysis of Parkinson’s disease iPS cell-derived neurons predicts genotype and reveals mitochondria–lysosome abnormalities
Mitochondrial and lysosomal dysfunction are central features of Parkinson’s disease (PD) across major genetic forms including PRKN , SNCA , and LRRK2 . We applied cell morphomics, a machine-learning-based framework combining high-content imaging with quantitative feature extraction, to analyse mitochondrial and lysosomal morphology at single-cell resolution in iPS cell-derived cortical neurons from PD patients and healthy controls (13 lines total). Supervised machine-learning models distinguished PD neurons from controls with high accuracy (AUC = 0.87) and reliably separated individual genotypes. Feature importance and attribution analysis revealed genotype-specific organelle biases, with mitochondrial features dominating classification in PRKN neurons, balanced mitochondrial and lysosomal contributions in SNCA neurons, and a greater lysosomal contribution in LRRK2 neurons. Multi-class models retained strong performance, and findings were reproduced across two independent laboratories using different dyes and imaging conditions. These results demonstrate that morphomics provides a robust and scalable framework to quantify genotype-specific organelle abnormalities in PD neurons and supports its application for cellular stratification and biomarker discovery.
Open AccessMachine learning–based image analysis of Parkinson’s disease iPS cell-derived neurons predicts genotype and reveals mitochondria–lysosome abnormalities
Mitochondrial and lysosomal dysfunction are central features of Parkinson’s disease (PD) across major genetic forms including PRKN , SNCA , and LRRK2 . We applied cell morphomics, a machine-learning-based framework combining high-content imaging with quantitative feature extraction, to analyse mitochondrial and lysosomal morphology at single-cell resolution in iPS cell-derived cortical neurons from PD patients and healthy controls (13 lines total). Supervised machine-learning models distinguished PD neurons from controls with high accuracy (AUC = 0.87) and reliably separated individual genotypes. Feature importance and attribution analysis revealed genotype-specific organelle biases, with mitochondrial features dominating classification in PRKN neurons, balanced mitochondrial and lysosomal contributions in SNCA neurons, and a greater lysosomal contribution in LRRK2 neurons. Multi-class models retained strong performance, and findings were reproduced across two independent laboratories using different dyes and imaging conditions. These results demonstrate that morphomics provides a robust and scalable framework to quantify genotype-specific organelle abnormalities in PD neurons and supports its application for cellular stratification and biomarker discovery.
- Open Access
- 20 June 2025
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 11 (1) , 1-14
Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction
Mutations causing Parkinson’s disease (PD) give diverse pathological phenotypes whose cellular correlates remain to be determined. Those with PRKN mutations have significantly earlier selective vulnerability of dopamine neurons, those with SNCA mutations have increased alpha-synuclein deposition, while those with LRRK2 mutations have additional deposition of tau. Yet all three mutation types are implicated in mitochondrial and/or lysosomal dysfunction. To compare cellular dysfunctions associated with these different pathological phenotypes, an unbiased high-content imaging platform was developed to assess both lysosomal and mitochondrial dysfunction, along with alpha-synuclein and tau protein deposition using induced pluripotent stem cell (iPSC) derived cortical and ventral midbrain neurons. Different PD mutations caused cell type specific dysfunctions, likely to impact on both selective neuronal vulnerability and the pathologies observed in PD. Comparison of dopamine neurons identified that both lysosomal and mitochondrial dysfunction were predominant with PRKN lof mutations, whereas SNCA A53T and LRRK2 R1441G mutations had increased tau deposition. In contrast, cortical neurons with SNCA and LRRK2 mutations both had mitochondrial and autophagy impairments without protein deposition, with LRRK2 cells additionally showing decreased glucocerebrosidase activity and increased alpha-synuclein phosphorylation.
- 20 June 2025
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 11 (1) , 1-14
Open AccessDopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction
Mutations causing Parkinson’s disease (PD) give diverse pathological phenotypes whose cellular correlates remain to be determined. Those with PRKN mutations have significantly earlier selective vulnerability of dopamine neurons, those with SNCA mutations have increased alpha-synuclein deposition, while those with LRRK2 mutations have additional deposition of tau. Yet all three mutation types are implicated in mitochondrial and/or lysosomal dysfunction. To compare cellular dysfunctions associated with these different pathological phenotypes, an unbiased high-content imaging platform was developed to assess both lysosomal and mitochondrial dysfunction, along with alpha-synuclein and tau protein deposition using induced pluripotent stem cell (iPSC) derived cortical and ventral midbrain neurons. Different PD mutations caused cell type specific dysfunctions, likely to impact on both selective neuronal vulnerability and the pathologies observed in PD. Comparison of dopamine neurons identified that both lysosomal and mitochondrial dysfunction were predominant with PRKN lof mutations, whereas SNCA A53T and LRRK2 R1441G mutations had increased tau deposition. In contrast, cortical neurons with SNCA and LRRK2 mutations both had mitochondrial and autophagy impairments without protein deposition, with LRRK2 cells additionally showing decreased glucocerebrosidase activity and increased alpha-synuclein phosphorylation.
- Open Access
- 14 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Single-cell mitochondrial morphomics reveals cellular heterogeneity and predicts complex I, III, and ATP synthase Inhibition responses
Mitochondrial heterogeneity drives diverse cellular responses in neurodegenerative diseases, complicating the evaluation of mitochondrial dysfunction. In this study, we describe a high-throughput imaging and analysis approach to investigate cell-to-cell mitochondrial variability. We applied known mitochondrial function inhibitors - rotenone, antimycin, and oligomycin to inhibit complexes I, III, and V (ATP synthase) function in human induced pluripotent stem cell-derived cortical neurons, a model commonly used in neurodegenerative disease research. We captured a large number of cell images and extracted a diverse range of mitochondrial morphological features related to shape, size, texture, and spatial distribution, for an unbiased and comprehensive analysis of mitochondrial morphology. Group-level cell analysis, which examines the collective responses of cells exposed to the same mitochondrial inhibitor, showed that cells treated with rotenone, antimycin, or oligomycin clustered together based on their shared morphological changes. Rotenone and antimycin, both targeting different complexes of the electron transport chain, formed sub-clusters within a larger cluster. In contrast, oligomycin, which inhibits ATP synthase, resulted in a distinct cluster likely due to its differing effect on ATP production. Single-cell analysis using dimensionality reduction techniques revealed distinct subpopulations of cells with varying degrees of sensitivity to each mitochondrial inhibitor, identifying the most affected cells. Mitochondrial feature differential expression analysis showed that neurite-related mitochondrial features, such as intensity and size, were more severely impacted than cell body-related mitochondrial features, particularly with rotenone and antimycin, which target the electron transport chain. In contrast, oligomycin which affects ATP synthesis by directly inhibiting ATP synthase showed relatively less severe alterations in neurite-related mitochondrial features, highlighting a distinct effect of the mode of action between inhibitors. By incorporating the most affected cells into machine learning models, we significantly improved the prediction accuracy of mitochondrial dysfunction outcomes − 81.97% for antimycin, 75.12% for rotenone, and 94.42% for oligomycin. This enhancement underscores the value of targeting highly responsive cell subpopulations, offering a more precise method for evaluating mitochondrial modulators and therapeutic interventions in neurodegenerative diseases.
- 14 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Open AccessSingle-cell mitochondrial morphomics reveals cellular heterogeneity and predicts complex I, III, and ATP synthase Inhibition responses
Mitochondrial heterogeneity drives diverse cellular responses in neurodegenerative diseases, complicating the evaluation of mitochondrial dysfunction. In this study, we describe a high-throughput imaging and analysis approach to investigate cell-to-cell mitochondrial variability. We applied known mitochondrial function inhibitors - rotenone, antimycin, and oligomycin to inhibit complexes I, III, and V (ATP synthase) function in human induced pluripotent stem cell-derived cortical neurons, a model commonly used in neurodegenerative disease research. We captured a large number of cell images and extracted a diverse range of mitochondrial morphological features related to shape, size, texture, and spatial distribution, for an unbiased and comprehensive analysis of mitochondrial morphology. Group-level cell analysis, which examines the collective responses of cells exposed to the same mitochondrial inhibitor, showed that cells treated with rotenone, antimycin, or oligomycin clustered together based on their shared morphological changes. Rotenone and antimycin, both targeting different complexes of the electron transport chain, formed sub-clusters within a larger cluster. In contrast, oligomycin, which inhibits ATP synthase, resulted in a distinct cluster likely due to its differing effect on ATP production. Single-cell analysis using dimensionality reduction techniques revealed distinct subpopulations of cells with varying degrees of sensitivity to each mitochondrial inhibitor, identifying the most affected cells. Mitochondrial feature differential expression analysis showed that neurite-related mitochondrial features, such as intensity and size, were more severely impacted than cell body-related mitochondrial features, particularly with rotenone and antimycin, which target the electron transport chain. In contrast, oligomycin which affects ATP synthesis by directly inhibiting ATP synthase showed relatively less severe alterations in neurite-related mitochondrial features, highlighting a distinct effect of the mode of action between inhibitors. By incorporating the most affected cells into machine learning models, we significantly improved the prediction accuracy of mitochondrial dysfunction outcomes − 81.97% for antimycin, 75.12% for rotenone, and 94.42% for oligomycin. This enhancement underscores the value of targeting highly responsive cell subpopulations, offering a more precise method for evaluating mitochondrial modulators and therapeutic interventions in neurodegenerative diseases.